IL51572A - 2-amino-6-substituted-9-(poly-ethyleneglycol)-methylpurines,esters thereof and pharmaceutical compositions containing them and intermediates therefor - Google Patents

2-amino-6-substituted-9-(poly-ethyleneglycol)-methylpurines,esters thereof and pharmaceutical compositions containing them and intermediates therefor

Info

Publication number
IL51572A
IL51572A IL51572A IL5157277A IL51572A IL 51572 A IL51572 A IL 51572A IL 51572 A IL51572 A IL 51572A IL 5157277 A IL5157277 A IL 5157277A IL 51572 A IL51572 A IL 51572A
Authority
IL
Israel
Prior art keywords
methylpurines
ethyleneglycol
esters
poly
amino
Prior art date
Application number
IL51572A
Other languages
English (en)
Other versions
IL51572A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL51572A0 publication Critical patent/IL51572A0/xx
Publication of IL51572A publication Critical patent/IL51572A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL51572A 1976-03-01 1977-03-01 2-amino-6-substituted-9-(poly-ethyleneglycol)-methylpurines,esters thereof and pharmaceutical compositions containing them and intermediates therefor IL51572A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,899 US4060616A (en) 1976-03-01 1976-03-01 Purine derivatives with repeating unit

Publications (2)

Publication Number Publication Date
IL51572A0 IL51572A0 (en) 1977-05-31
IL51572A true IL51572A (en) 1980-07-31

Family

ID=24659686

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51572A IL51572A (en) 1976-03-01 1977-03-01 2-amino-6-substituted-9-(poly-ethyleneglycol)-methylpurines,esters thereof and pharmaceutical compositions containing them and intermediates therefor

Country Status (18)

Country Link
US (1) US4060616A (es)
JP (1) JPS52111594A (es)
AT (1) AT360552B (es)
AU (1) AU506227B2 (es)
BE (1) BE851974A (es)
CA (1) CA1075237A (es)
CH (2) CH629807A5 (es)
DE (1) DE2708828A1 (es)
DK (1) DK142546B (es)
ES (2) ES456407A1 (es)
FR (1) FR2342971A1 (es)
GB (1) GB1569393A (es)
HU (1) HU180321B (es)
IL (1) IL51572A (es)
NL (1) NL7702176A (es)
NZ (1) NZ183468A (es)
SE (1) SE430505B (es)
ZA (1) ZA771219B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US20110059921A1 (en) * 2008-03-27 2011-03-10 Ektar Therapeutics Oligomer-Nitrogenous Base Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof

Also Published As

Publication number Publication date
SE430505B (sv) 1983-11-21
CH629807A5 (de) 1982-05-14
NL7702176A (nl) 1977-09-05
JPS6222994B2 (es) 1987-05-20
AU506227B2 (en) 1979-12-20
ES467943A1 (es) 1978-11-01
BE851974A (fr) 1977-09-01
DK88977A (es) 1977-09-02
FR2342971A1 (fr) 1977-09-30
HU180321B (en) 1983-02-28
SE7702231L (sv) 1977-09-02
DK142546C (es) 1981-08-03
ATA134777A (de) 1980-06-15
NZ183468A (en) 1979-04-26
AU2276077A (en) 1978-09-07
US4060616A (en) 1977-11-29
DE2708828A1 (de) 1977-09-08
CH632759A5 (de) 1982-10-29
CA1075237A (en) 1980-04-08
IL51572A0 (en) 1977-05-31
DK142546B (da) 1980-11-17
JPS52111594A (en) 1977-09-19
FR2342971B1 (es) 1978-11-03
ZA771219B (en) 1978-10-25
AT360552B (de) 1981-01-26
ES456407A1 (es) 1978-07-01
GB1569393A (en) 1980-06-11

Similar Documents

Publication Publication Date Title
JPS52143218A (en) Pharmaceutical composition
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
PH23643A (en) Nasal pharmaceutical composition
JPS52113976A (en) Pharmaceutical composition
JPS5362838A (en) Pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
JPS5372814A (en) Pharmaceutical composition
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
IL55382A0 (en) Novel propenylamines, their production and pharmaceutical compositions containing them
IL54950A0 (en) New peptide derivatives,their production and pharmaceutical compositions containing them
IL56241A0 (en) New peptide derivatives, their manufacture and pharmaceutical compositions containing them
IL54967A0 (en) Novel peptides and pharmaceutical compositions containing them
AU3152677A (en) Pharmaceutical composition
NZ184394A (en) N-acyl-l-alanyl -aminoacyl-amides intermediates and pharmaceutical compositions
IL51572A (en) 2-amino-6-substituted-9-(poly-ethyleneglycol)-methylpurines,esters thereof and pharmaceutical compositions containing them and intermediates therefor
IL55207A0 (en) Novel benzodiazepine-diones,their production and pharmaceutical compositions containing them
IL54714A0 (en) Novel polypeptide derivatives, their production and pharmaceutical compositions containing them
JPS5356634A (en) Pharmaceutical composition
AU2649977A (en) Pharmaceutical composition
IL56150A0 (en) New tetrapeptides, their manufacture and pharmaceutical compositions containing them
IL55018A0 (en) Novel benzylpyrimidines, their manufacture and pharmaceutical compositions containing them
IL54105A0 (en) Novel benzylpyrimidines, their production and pharmaceutical compositions containing them
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
JPS549283A (en) Benzoisothiazolone * production thereof and pharmaceutical composition containing same
NZ182368A (en) 1,9-dihydroxy-hexahydrodib-enzipyrans intermediates and pharmaceutical compositions